Olfm2 Blocking peptide (C terminal region)

Olfm2 Blocking peptide (C terminal region)
Artikelnummer
AVIAAP93771-100
Verpackungseinheit
100µg
Hersteller
Aviva Systems Biology

Verfügbarkeit: wird geladen...
Preis wird geladen...
Description of Target: Involved in transforming growth factor beta (TGF-beta)-induced smooth muscle differentiation (By similarity). TGF-beta induces expression and nuclear translocation of OLFM2 where it binds to SRF, causing its dissociation from the transcriptional repressor HEY2/HERP1 and facilitating binding of SRF to target genes (By similarity). Plays a role in AMPAR complex organization. Is a regulator of vascular smooth-muscle cell (SMC) phenotypic switching, that acts by promoting RUNX2 and inhibiting MYOCD binding to SRF. SMC phenotypic switching is the process through which vascular SMCs undergo transition between a quiescent contractile phenotype and a proliferative synthetic phenotype in response to pathological stimuli. SMC phenotypic plasticity is essential for vascular development and remodeling (By similarity).

Product Format: Lyophilized powder

Protein Size: 448
Mehr Informationen
Artikelnummer AVIAAP93771-100
Hersteller Aviva Systems Biology
Hersteller Artikelnummer AAP93771-100UG
Green Labware Nein
Verpackungseinheit 100µg
Mengeneinheit STK
Methode Western Blotting
Human Gene ID 244723
Produktinformation (PDF)
×
MSDS (PDF)
×